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April 6, 2010:1502–8f mortality and hospital stay. This result is misleading. Should we
ow offer RPM to the millions of heart failure outpatients? The
ost recent trials (2,3) failed to demonstrate convincing benefits in
hese end points. What caused the discrepancy? In the era of good
aseline medication, growing defibrillator implantation rates,
cheduled visits, and good self care, it is essential to identify the
atients who might benefit from additional RPM and also those
ho will not. What are the determinants of outpatient responsive-
ess? When should RPM be used and for how long? What systems
re most suitable? What makes interventions effective? Apart from
he diversity of healthcare delivery systems requiring coordination
n each country, there might be disease-related determinants of
eceptivity to RPM. The efforts of future trials should focus on
hese aspects. The challenge is to identify patients who require
aily contact with healthcare experts as well as those who can
ontinue to receive usual care without harm. A very smart
echnology calls for very intelligent clinical implementation.
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eply
e thank Drs. Winkler and Koehler for their interest in our report
1) regarding the assessment of effect of remote patient monitoring on
he outcome of chronic heart failure patients. We appreciated their
rovocative thoughts about unmet needs in structured disease man-
gement program (e.g., identification of the patients who most likely
enefit from the technology, determinants of outpatient responsive-
ess, what makes interventions effective), which we all share; however,
e are afraid that none of these questions might have found an
nswer, given the lack of published data. As far as the differences in
utcome of 2 of the most recently published studies and the results of
ur meta-analysis are concerned, we believe that they are much less
han what Drs. Winkler and Koehler perceived.
The study by Mortara et al. (2) showed a similar outcome
etween usual care and remote monitoring (indicated in the study
s home telemonitoring). However, patients in the Mortara et al.
tudy were at least 5 to 10 years younger than those included in our
eta-analysis, and they were in a much lower New York Heart
ssociation (NYHA) functional class (ranging from 34% to 49%n NYHA functional class 3 compared with 54% [randomized
ontrolled trials] and 83% [observation cohorts] in our meta-
nalysis). Moreover, there was an unexplained imbalance, as
lready emphasized by Mortara et al., in baseline characteristic in
he large Polish cohort as indicated by a more advanced NYHA
unctional class, significantly lower left ventricular ejection frac-
ion, higher dyspnea score, and much lower sodium plasma level
or those patients assigned to home telemonitoring. A post hoc
nalysis revealed a highly significant interaction between home
elemonitoring and country in the association with the number of
ospital stays (p  0.004) and in the combined end point of
ardiac death and heart failure hospital stay (p  0.004). If one
ould put in perspective the outcome of the Italian cohort of the
tudy by Mortara et al. with the results of our meta-analysis, an
mpressive similar benefit of remote monitoring compared with
sual care would be found.
The study by Dar et al. (3) was a small, prospective, randomized
ontrolled study including 182 patients randomized to usual care
ersus home monitoring. Although the baseline demographic
haracteristics of these patients were similar to those reported in
he studies included in our meta-analysis, only 74 patients in the
ome monitoring arm and 79 patients in the usual care completed
80-day follow-up. Thus, the relative weight of the study by Dar
t al. (3) in our meta-analysis would be relatively low, and
mportantly, approximately 50% of the studies we meta-analyzed
ad a similar duration of follow-up. Of note, there were 14 deaths
n the home monitoring arm and only 4 deaths in the usual care
roup. Overall, this was an extremely high death rate for a very
hort follow-up but also impressively different between 2 treat-
ents. We were not able to find any comparative study in our
eta-analysis reporting similar death rates, which let us question
bout the reasons (not addressed in the study). Indeed, the death
ate at 12 months in all randomized controlled studies we meta-
nalyzed ranged from 14.1% (95% confidence interval [CI]: 12.8 to
5.4) to 11.7% (95% CI: 10.7 to 12.9) in the usual care and home
onitoring arm, respectively, and in observational studies it ranged
rom 13.0% (95% CI: 10.9 to 15.3) to 6.8% (95% CI: 5.3 to 8.6).
In conclusion, there is no doubt that the studies by Mortara et
l. (2) and Dar et al. (3) both represent important contributions to
mplementation of remote monitoring. Their relative weight needs
o be defined in future meta-analysis, keeping in mind some
mportant methodological issues of each study.
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ot Just Coronary Arteritis,
awasaki Disease Is
Myocarditis, Too
here is a great deal of insight in the points of view addressed
ecently by Gordon et al. (1) and by Gersony (2). One could not
ut notice an unbalanced aspect in the commentary article,
owever. This has nothing to do with the respected opinion of Dr.
ersony; on the contrary, it has to do with the general miscon-
eption connecting Kawasaki disease (KD) to merely 1 fact: the
elated coronary artery complications. The original editorial article
y Gordon et al. (1) is intended to convey a message to the Adult
ardiology Society urging for an educated awareness of the
erceived impact of the KD-related cardiovascular disturbances
eyond childhood. Whether some aspects of the disease gained the
eserved emphasis in the original review article or not, the rebuttal
ommentary was completely distracted from essential realities associ-
ted with KD. Although Gordon et al. (1) identified the often-
issed importance of the consequences of KD on the myocardium,
ersony (2) limited his discussion to the sole coronary artery
omplications of the disease. That is exactly the problem. In my
ind, it is important to put a brake on the problematic coronary
neurysms, be it only for a minute. The hidden face of the moon
n this disease, the myocarditis, must not be underestimated (3)
his myocarditis is evidenced by serial myocardial biopsy studies
rom patients without coronary aneurysms (4,5). It is also sug-
ested by echocardiography studies (6) and by biochemical markers
eflecting the myocardial response to the inflammatory process
pon the onset of the disease (7). Four decades since the initial
ecognition of KD as a separate entity from resembling ailments
ave not permitted researchers to uncover its etiology. The
nflammatory involvement of the myocardium and its long-term
onsequences deserve a serious look and a methodological
ollow-up.
The incidence of KD is on the rise, not only because of the
odified diagnostic paradigm, which encourages the diagnosis of
ases with incomplete clinical criteria (8,9), but also because of the
ecent awareness of the diagnosis, not only in North America but
lso in the most populous countries of the globe as well (10,11). It
s appropriate and wise to inform KD patients that there are
nsufficient data to adequately calculate their cardiovascular prog-
osis, with the exception of the minority who sustained a severe
oronary artery injury. Should we wish to care for the remaining
9% of KD patients, the myocarditis trail—not just that of the
oronary arteries—needs to be followed. And as Gersony (2)
orrectly concludes, the American Heart Association guidelines are
imply guidelines, subject to continuous updates.
Now, back to the injured coronary arteries, resolved or unre-
olved. If making patients aware of their antecedent KD diagnosis
s a potential cardiovascular risk factor deeply affects their psyche,
hen physicians must also refrain from discussing obesity, for ixample, when counseling primary or secondary prevention of
ardiovascular diseases.
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eply
thank Dr. Dahdah for his interest in my paper (1). In his letter
o the editor, Dr. Dahdah raises concerns about the long-term
ffects of myocarditis on adults who had Kawasaki disease (KD) as
child, and that my commentary, which pertained to the risk of
ate coronary artery events, did not address this potential issue. As
e indicates, a myocardial inflammatory process in the acute phase
f KD has been well documented, even when coronary involve-
ent may have been minimal or even absent. However, Dr.
ahdah’s assertion that late manifestations of acute myocarditis
re likely to be a serious threat to the adult who had KD is not
vidence based. The references accompanying his letter do not
escribe a single case of an adult with late myocarditis or
onischemic cardiomyopathy, and there have been hundreds of
housands of patients who have had KD. Furthermore, the biopsy
tudies carried out in 1978 and 1981 were obtained from patients
n the acute and subacute phases of the disease. By no means can
